View corporate snapshot here: www.replicel.co....
RepliCel Life Sciences is developing an autologous cell-based procedure for the treatment of androgenetic alopecia (pattern baldness) and general hair loss in men and women. The procedure has the potential to become the first minimally invasive solution for hair loss.
Негізгі бет Replicel.com | RCH-01 Technology Video
Пікірлер: 53